The purpose of this study is to investigate the effects of using durvalumab plus platinum doublet chemotherapy (carboplatin/abraxane or carboplatin/pemetrexed) with or without abequolixron (RGX-104) in patients with non-small cell lung cancer (NSCLC) before surgery.
COM_RESEARCHSTUDIES_DETAIL_HEADER_BASIC_CONTACT_4
North Carolina (Statewide)
Jared Weiss
Medicine- Oncology
Clinical or Medical
Interventional
Cancer (Lung)
22-2739